Touchstone International Medical Science Co Ltd - Asset Resilience Ratio
Touchstone International Medical Science Co Ltd (688013) has an Asset Resilience Ratio of 37.86% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Touchstone International Medical Science Co Ltd's Asset Resilience Ratio has changed over time. Check Touchstone International Medical Science (688013) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Touchstone International Medical Science Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Touchstone International Medical Science.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥255.91 Million | 37.86% |
| Total Liquid Assets | CN¥255.91 Million | 37.86% |
Asset Resilience Insights
- Very High Liquidity: Touchstone International Medical Science Co Ltd maintains exceptional liquid asset reserves at 37.86% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Touchstone International Medical Science Co Ltd Industry Peers by Asset Resilience Ratio
Compare Touchstone International Medical Science Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sartorius Aktiengesellschaft
XETRA:SRT3 |
Medical Instruments & Supplies | 0.26% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
Crossject
PA:ALCJ |
Medical Instruments & Supplies | 1.31% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Annual Asset Resilience Ratio for Touchstone International Medical Science Co Ltd (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Touchstone International Medical Science Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 51.94% | CN¥331.00 Million ≈ $48.44 Million |
CN¥637.24 Million ≈ $93.25 Million |
+17.07pp |
| 2023-12-31 | 34.87% | CN¥218.52 Million ≈ $31.98 Million |
CN¥626.61 Million ≈ $91.69 Million |
-25.72pp |
| 2022-12-31 | 60.59% | CN¥329.28 Million ≈ $48.18 Million |
CN¥543.46 Million ≈ $79.52 Million |
-4.66pp |
| 2021-12-31 | 65.25% | CN¥355.49 Million ≈ $52.02 Million |
CN¥544.83 Million ≈ $79.73 Million |
+13.20pp |
| 2020-12-31 | 52.05% | CN¥252.56 Million ≈ $36.96 Million |
CN¥485.24 Million ≈ $71.01 Million |
-- |
About Touchstone International Medical Science Co Ltd
Touchstone International Medical Science Co., Ltd. researches and develops, manufactures, and sells medical devices in China, the United States, Europe, Japan, Russia, Brazil, South Korea, Canada, Australia, and internationally. It provides laparoscopic, tube-type, intraluminal, endoscopic linear cutters and reloads, linear cutters and reloads, auto purse string clamps, and linear staplers and re… Read more